Latest News - Baxter

Top Corporates Hub

Baxter

BAX | NYSE | United States
953
Rank
$17.79B
Market Cap
$11.75B
-$ 1.95B
-14.23%
Revenue
$0.12B
Earnings
38K
Employees
Medical Affairs Leader Dr. Kirk Shepard Joins BP Logix’s Life Sciences Strategic Advisory Board

26.08.2025 11:00

SAN DIEGO, August 26, 2025--As part of its mission to drive innovation in Medical Affairs automation, BP Logix is pleased to announce the appointment of Dr. Kirk Shepard to the company's Life Sciences Strategic Advisory Board.

Read More

Sigmoidoscopes Market Insights, Competitive Landscape, and Forecast 2022-2024 & 2025-2032 | North America, Healthcare Advancements and Geriatric Populations Drive Growth

08.08.2025 11:13

The sigmoidoscopes market, segmented by product type, usability, end-user, and geography, is forecasted to grow at a 5.57% CAGR from 2025 to 2032. This growth is driven by rising chronic conditions, a growing geriatric population, and increased awareness about early diagnosis of gastrointestinal disorders globally. North America is expected to dominate the market, aided by technological innovations and healthcare investments. Key players include Olympus Corporation, Baxter, and Johnson & Johnson

Read More

Baxter International Inc. (BAX): A Bull Case Theory

06.08.2025 02:37

We came across a bullish thesis on Baxter International Inc. on DeepValue Capital’s Substack. In this article, we will summarize the bulls’ thesis on BAX. Baxter International Inc.’s share was trading at $22.44 as of August 4th. BAX’s trailing and forward P/E were 84.46 and 8.71, respectively according to Yahoo Finance. Baxter International (BAX), a nearly century-old […]

Read More

Stifel downgrades Baxter as it sees longer path to recovery under new CEO

04.08.2025 14:09

Investing.com -- Stifel downgraded Baxter International (NYSE:BAX) to Hold from Buy and slashed its price target to $25 from $36, citing a weaker-than-expected second quarter and a longer timeline for operational turnaround under incoming CEO Andrew Hider.

Read More

Baxter’s shares fall 23% following tepid Q2 2025 financials

04.08.2025 12:19

The Q2 results, that missed analyst estimates, also led to a trimming of Baxter’s 2025 outlook.

Read More

Are Wall Street Analysts Bullish on Baxter International Stock?

04.08.2025 11:10

While Baxter International has lagged the broader market over the past year, Wall Street analysts remain cautiously optimistic about its future potential.

Read More

Europe Syringe Infusion Pump Market Analysis Report 2025-2030, with Key Player Profiles for B. Braun, Baxter, Fresenius Kabi, Micrel Medical Devices, CODAN, Acromed, ICU Medical, Terumo, and Moog

04.08.2025 08:08

The European Syringe Infusion Pump Market, valued at USD 465.1M in 2024, is projected to reach USD 729.5M by 2030, growing at a 7.90% CAGR. This growth is driven by rising preterm births, chronic diseases, and advanced technology adoption. Leading segments include pediatrics/neonatology and hospitals. Germany holds the largest market share, with rapid growth expected in home care. The report offers detailed market analysis, future trends, and actionable recommendations for strategic decision-mak

Read More

Blood Purification Devices Market Competitive Landscape, and Market Forecasts to 2032

01.08.2025 14:12

The Blood Purification Devices Market is expected to grow at a 5.40% CAGR, reaching USD 26.86 billion by 2032. Growth factors include rising kidney disease cases, hypertension, and diabetes. Key segments are CRRT devices, with North America leading. Major players include Fresenius, B. Braun, and Baxter.Dublin, Aug. 01, 2025 (GLOBE NEWSWIRE) -- The "Blood Purification Devices - Market Insights, Competitive Landscape, and Market Forecast - 2032" has been added to ResearchAndMarkets.com's offering.

Read More

Avis Budget downgraded, Sprouts upgraded: Wall Street's top analyst calls

01.08.2025 13:34

Avis Budget downgraded, Sprouts upgraded: Wall Street's top analyst calls

Read More

InMode (INMD) Q2 Earnings and Revenues Beat Estimates

30.07.2025 12:10

InMode (INMD) delivered earnings and revenue surprises of +9.30% and +0.11%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

Read More

Baxter (BAX) Reports Earnings Tomorrow: What To Expect

30.07.2025 03:13

Healthcare company Baxter International (NYSE:BAX) will be reporting earnings this Thursday before market hours. Here’s what to expect.

Read More

Vizient Reserve Program Expands Supply Assurance to Include IV Fluids in Collaboration With Baxter

23.07.2025 10:00

IRVING, Texas, July 23, 2025--Vizient announced today the expansion of the Vizient Reserve Program to include IV fluids through a strategic partnership with Baxter.

Read More

3 Reasons to Avoid BAX and 1 Stock to Buy Instead

21.07.2025 04:04

Over the past six months, Baxter’s shares (currently trading at $27.77) have posted a disappointing 11.8% loss, well below the S&P 500’s 4.1% gain. This may have investors wondering how to approach the situation.

Read More

Baxter International looking to bounce back

08.07.2025 08:31

The medical equipment manufacturer, which has just completed a lengthy restructuring process, is now expected to enter a new phase following the appointment of Andrew Hider, a former Danaher...

Read More

Baxter appoints Andrew Hider as CEO

08.07.2025 04:49

Hider oversaw a series of tuck-in acquisitions to drive revenue growth as CEO of ATS.

Read More

BDJ: Attractive Monthly Distribution At A Discount

29.06.2025 13:13

Discover why BDJ is in the 'buy' zone with its call writing strategy, value-focused portfolio, and reliable monthly distributions.

Read More

5 Must-Read Analyst Questions From Baxter’s Q1 Earnings Call

26.06.2025 07:48

Baxter’s first quarter saw revenue and adjusted profit both exceed Wall Street expectations, but the market responded cautiously to the results. Management attributed the quarter’s performance to strong execution in Medical Products & Therapies as well as Healthcare Systems & Technologies, highlighting robust demand for infusion systems and progress in stabilizing IV solutions supply after earlier disruptions. Interim CEO Brent Shafer noted, “Our results reflect the building momentum of our stra

Read More

Is Baxter International Stock Underperforming the Nasdaq?

20.06.2025 11:47

Baxter International has underperformed the Nasdaq over the past year, but analysts are cautiously optimistic about the stock’s prospects.

Read More

$16.4 Bn Patient Handling Equipment Markets, 2030 by Patient Transfer (Ceiling Lifts, Stair Lifts, Slings), Medical Beds, Mobility Equipment (Walkers, Canes, Crutches), Stretchers

18.06.2025 11:34

The global patient handling equipment market is set to grow from USD 12.4 billion in 2025 to USD 16.4 billion by 2030, at a CAGR of 5.8%. Key growth drivers include the aging population and rising prevalence of cardiovascular diseases, necessitating advanced and ergonomic devices. A surge in home healthcare services across North America, Europe, and Asia Pacific further boosts demand. The patient transfer devices segment, particularly patient lifts, dominates due to increasing awareness and musc

Read More

UBS Affirms Neutral Rating on Baxter International (BAX)

17.06.2025 06:24

Baxter International Inc. (NYSE:BAX) is one of the 12 best healthcare stocks to buy now. On June 11, UBS reiterated a ‘Neutral’ rating on the stock and a $35 price target. The Neutral stance follows a meeting with the company’s Head of Investor Relations. According to UBS, the company has demonstrated momentum across its portfolio […]

Read More